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Abstract 
Introduction 
Background: Many studies in the literature have shown that Epstein-Barr virus (EBV) is associated with several 
human lymphoid and epithelial malignancies. However, the prevalence of EBV in non-Hodgkin lymphoma 
(NHL) of the lower gastrointestinal (Gl) tract has not been fully elucidated. 
Aim: The aim of this study was to determine the presence and distribution of EBV in formalin-fixed 
paraffin-embedded tissue samples obtained from 18 Malaysian patients diagnosed with NHL of the lower GI 
tract. 
Methods: The GI tract lymphoma tissue samples analyzed for the presence of EBV were divided into the 
following groups: NHL of the smalJ intestine (seven cases); NHL of the ileocecum {ten cases); and NHL of the 
rectum {one case). The presence ofEBV-encoded RNA (EBER) in all of the above tissue samples was tested for 
using conventional in situ hybridization technology. · 
Results: Two of 18 cases (11.1%) ofNin.. of the lowerGI tract demonstrated positive signals forEBVIEBER. In 
the first positive case, EBV lEBER signals were located in lymphoma cells in the serosa layer of the small 
intestine. In the second EBVIEBER-positive case, EBVIEBER signals were detected in diffuse B-celllymphoma 
of the ileocecum. 
Conclusion: These findings demonstrate a rare association between EBV and lower GI tract lymphomas in this 
group of Malaysian patients. 
This study was initiated to determine the prevalence of Epstein-
Barr virus (EBV) in lower gastrointestinal (GI) tract lymphomas. 
To date, no studies have been conducted to determine the preva-
lence of EBV in NHL of the lower GI tract in the Malaysian 
population. In addition. and to our knowledge, there has been only 
one case study that has looked at the prevalence ofEBV in NHL of 
the ileocecum181 and only a few case-report studies that have 
looked at the prevalence ofEBV in NHL of the small intestine.l9·11J 
EBV was discovered 40 years ago during examination of 
electron micrographs of cells cultured from a Burkitt lymphoma 
sample.l1l This finding became the first of an unexpectedly wide 
range of associations between EBV and malignancies.121 
In general, lymphoma is defined as a primary malignant tumor 
of the lymphoid cells (nodal or extra-nodal). There are two types 
of lymphoma; Hodgkin lymphoma (HL) and non-Hodgkin lym-
phoma (NHL). Lymphomas, which are ranked the 12th most 
common cancer in the world, are more prevalent in men than 
women.l3.4J 
Many published studies have shown that EBV is associated 
with several human lymphoid and epithelial celJ malignancies.l.S.71 
The experimental approach used in our study for the detection 
of EBV in NHL of the lower GI tract was in situ hybridization 
(ISH). The probe used was the EBV-encoded RNA (EBER)IEBV 
probe. EBER ISH is considered as the gold standard technique for 
detecting and localizing latent EBV in tissue samples.ll21 
Here, we report the prevalence of EBV in lower GI tract 
lymphomas collected from 18 Malaysian patients between 1992 
and 2004. 
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Materials and Methods 
Tissue Specimens 
This study was carried out on 18 fonnalin-fixed paraffin-
embedded tissue samples obtained from Malaysian patients with 
NHL of the lower GI tract. The lymphoma tissue samples used in 
our study were divided into the following groups: NHL of the 
small intestine (seven cases); NHL of the ileocecum (ten cases); 
and NHL of the rectum (one case). All of these samples were 
collected in the Department of Pathology at the Universiti Sains 
Malaysia, over a period of 12 years from 1992 to 2004 and 
represent all of the lower GI tract lymphomas seen at our institu-
tion during this period. Patient data consisted of age, sex, clinical 
details, and histopathology results (see table 1). The patients con-
sisted of 11 males and 7 females, with a mean age of 44.78 years, 
ranging from 2 years to 77 years. None of the patients included in 
the present study was immunosuppressed. 
This study was approved by the School of Medical Sciences 
ethical committee, Universiti Sains Malaysia, in accordance with 
the Malaysian guideline. 
The slides stained with hematoxylin and eosin were reviewed 
by two independent pathologists. The phenotyping of the 
lymphomas was perfonned using standard avidin-biotin complex 
immunohistochemical staining, using primary antibodies (DAKO, 
Denmark) directed against B-cell associated antigen CD20 (L26}, 
T-cell associated antigens CD45RO (UCHLJ), and T-cell specific 
antigen CD3 (polyclonal anti-CD3). 
Positive Control Tissue Samples 
All positive control tissue samples used were nasopharyngeal 
carcinoma (NPC) tissue sections, known to be positive for EBV/ 
EBER. 
In Situ Hybridization 
The irz situ hybridization (ISH) probe used for the detection of 
EBV in all non-Hodgkin lymphomas of the IowerGI tract that had 
been histopathologically confinned was the peptide nucleic acid 
(PNA) EBV/EBER specific probe (DakoCytomation, Denmark). 
The detection kit for ISH was the PNA ISH Detection kit (Dako-
Cytomation, Denmark), intended for the detection of fluorescein-
conjugated PNA prohes hybridized to their target RNA in cell or 
tissue preparations. 
In each experiment a positive and negative control were includ-
ed. The negative control consisted of a serial section to the test 
sample, treated with a negative control probe (provided by the kit 
manufacturer). The ISH experiments were carried out as instructed 
C 2006 Adis Data lnfoonation BV. AD rights reseiVed. 
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by the kit manufacturer, and aJI precautions were taken to avoid 
RNase contamination. 
Counterstaining and Mounting 
The sections were counterstained with Nuclear Fast Red 
(DakoCytomalion, Denmark), mounted with aqueous mounting 
solution (Merck, Gennany), and a coverslip was placed on top. 
Positive staining to EBV lEBER was visualized under light 
microscopy as a dark blue/black stain over the target site. 
Results 
Histopathology 
Histopathological features for aU the cases of NHL of the lower 
GI tract were recorded by two independent pathologists who 
examined slides stained with hematoxylin and eosin. The patients' 
details, clinical data, and histopathology are shown in table I. 
In Situ Hybridization 
EBV/EBER in non-Hodgkin Lymphomas of the Small Intestine 
Seven samples from patients with NHL of the small intestine 
were analyzed by ISH for the presence of EBV lEBER. One 
sample was positive for EBV/EBER (14.3%). Positive siga1als for 
EBV/EBER were located in lymphoma cells of the serosal layer 
(figure 1 and table 1). All negative controls, from serial sections to 
the test samples, were tested using a negative-control probe, and 
proved negative for EBVIEBER (figure 1 and table 1). All the 
positive-control tissue samples consisted of NPC, were processed 
at the same time as test samples, and proved positive to EBV/ 
EBER (figure 2). This indicates that the RNA was preserved and 
not degraded as a result of formalin fixation. 
EBV lEBER in non-Hodgkin lymphomas of the Ileocecum 
Ten samples of NHL of the ileocecum were analyzed by ISH 
for the presence of EBV lEBER. One sample was positive for 
EBVIEBER (10%). Positive signals for EBV/EBER were located 
in scattered, diffuse B-cell lymphoma cells (figure 3 and table 1). 
All negative controls, from serial sections to the test samples, were 
tested using a negative-control probe, and proved negative for 
EBVIEBER (figure 3 and table 1). The NPC positive-control tissue 
samples were positive to EBVIEBER (figure 2). 
EBV/EBER In non-Hodgkin lymphomas of the Rectum 
The single sample ofNHL of the rectum was negative for EBV/ 
EBER. The negative-control tissue sample was negative for EBV/ 
EBER (table 1), while the pesitive control was positive for EBV/ 
EBER (figure 2). 
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Table 1. Demographic details, clinical data, and histopathology results for all patients diagnosed with non-Hodgkin lymphoma (NHL) of the lower 
gastrointestinal tract 
Patient Age 
no. {yrs) 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
38 
61 
2 
66 
77 
29 
38 
11 
3 
75 
73 
43 
50 
66 
34 
29 
48 
63 
Discussion 
Sex 
Male 
Female 
Male 
Male 
Male 
Female 
Male 
Female 
Male 
Female 
Male 
Male 
Male 
Female 
Male 
Female 
Male 
Female 
Site of 
lymphoma 
Duodenum 
Jejunum 
Jejunum 
Ileum 
Ileum 
Ileum 
Ileum 
Histopathology diagnosis 
(Working Formulation I WHO 
classification) 
Phenotype 
Small lymphocytic lymphoma I T cell/low grade 
lymphocytic 
Diffuse large B-cell lymphoma I B cell I high grade 
centroblastic-polymorphic 
Anaplastic large cell lymphoma I T cell/ high grade 
pleomorphic, medium and large cell 
Diffuse large B-cell lymphoma I B cell/ high grade 
centroblastic 
Anaplastic large cell lymphoma I T cell/ high grade 
anaplastic 
Diffuse large B-cell lymphoma I B-celll high grade 
centroblastic 
Diffuse large cell lymphoma I T cell I high grade 
immunoblastic 
Ileocecum Burkitt lymphoma I Burkitt's B cell/ high grade 
Ileocecum Burkitt lymphoma I Burkitrs B cell I high grade 
Ileocecum Diffuse large B-cell lymphoma I B cell I high grade 
centroblastic, centrocyctic 
Ileocecum Diffuse large B-een lymphoma I B cell I high grade 
centroblastic 
Ileocecum HPE-diffuse large B-cell lymphoma- not available 
immunoblastic variant I 
immunoblastic NHL 
Ileocecum Diffuse large B-cell lymphoma I B cell/ high grade 
centroblastic, centrocyctic 
Ileocecum Diffuse large B-een lymphoma: B cell 1 high grade 
anaplastic large B-eall variant I 
anaplastic 
Ileocecum Diffuse large B-cell lymphoma/ B cell I high grade 
centroblastic 
Ascending colon Diffuse large B-cell lymphoma I B cell/ high grade 
centrocyctic 
Ileocecum Diffuse large B-cell lymphoma: B cell I high grade 
anaplastic large B-cell variant I Ki 1 
lymphoma 
Rectum Metastatic NHL Not available 
Results of in situ 
hybridization analysis for 
Epstein-Barr virus (EBV)I 
EBV nucleic acid 
Negative 
Negative 
Negative 
Negative 
Negative 
Positive 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Positive 
Negative 
Negative 
Most of the cases of NHL of the lower Gl tract analyzed in the 
present study were high-grade B-cell lymphoma. B-cell 
lymphomas make up 80-85% of NHL at all anatomical sites. T-
een lymphomas form the large majority of the remainder of 
NHL.ltJJ 
The results of our study demonstrate a rare association between 
EBV and lower GI tract lymphoma, based on these tissue samples 
obtained from Malaysian patients. Only 2 of 18 cases of lower GI 
tract lymphomas were positive for EBVIEBER. In positive cases, 
EBVIEBER-positive signals were detected only in cases of high 
grade B-cell lymphoma. 
C 2006 Adis Doto lnformotion BV. All rights reserved. Mol Dlog Ther 2006: lO (4) 
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Fig. 1. In situ hybridization detection of Epstein-Barr virus (EBV)/EBV-
encoded RNA (EBEA) in a tissue sample of non-Hodgkin lymphoma (NHL) 
of the small intestine. a & b illustrate tissue stained with hematoxylin and 
eosin (original magnifications: a= x 100; b = x 200). c & d illustrate the 
corresponding serial tissue section to which the EBVIEBER probe was 
applied, showing EBV/EBER staining as blue/purple color (arrow) in the 
lymphoma cells of the serosal layer (original magnifications: c = x 1 00; d = 
x 400). e & f show the same serial section, to which a negative control 
probe was applied with no staining present (original magnifications: e = 
X 100; f:;; X 400). 
In this study, we investigated EBER transcripts by ISH because 
it is well established that two EBV-encoded RNAs (EBERl and 
EBER2) are expressed at high levels in latently infected ce11s 
(approximately 107 copies per cell).l 13• 18l 
In the first EBV/EBER-positive case reported here, EBV was 
detected in NHL of the small intestine. Only a few studies have 
previously shown an association between EBVIEBER and NHL of 
the small intestine.£9-IIJ Borisch et ai.l91 detected the EBV genome 
in lymphoma tissue by PCR, which was then localized via EBER 
ISH to some of the transformed lymphocytes.l91 Kersten et ai.l111 
@ 2006 Adis Doto Information BV. AS rights resEifVed. 
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Fig. 2. In situ hybridization detection of Epstein-Barr virus (EBV)/EBV-
encoded RNA (EBER) in positive control nasopharyngeal carcinoma 
(NPC) tissue samples. a & b illustrate NPC tissue sample stained with 
hematoxylin and eosin (original magnifications: a = x 200; b = x 400). c & d 
illustrate the corresponding serial NPC section to which the EBVIEBER 
prob~ was appl~ed. showing E.BY/EBER ~taining as blue/purple color (ar-
row) tn the ~rctno~a cells (o~gtnal magmfications: c :;; x 200, d = x 400). 
e & fare senal secttons to whtch a negative control probe was applied with 
no staining present (original magnifications: e:;; x 200; f:;; x 400). 
also reported the presence of EBV DNA in NHL of small intestine 
tissue from a kidney transplant patient. Yang et aiJIOJ reported one 
EBVIEBER-positive signal in 12 cases of NHL of the small 
intestine in a group of Korean patients. Another studyll91 that 
examined the prevalence of EBV in intestinal NHL in European 
and Mexican populations showed that the prevalence was hioher 
in the Mexican population than in the European population. 
0 
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Fig. 3. In situ hybridization detection of Epstein-Barr virus {EBV)IEBV-
encoded RNA (EBER). Example of the results for the analysis of non-
Hodgkin lymphoma (NHL) of the ileocecal tissue samples. a & b illustrate 
NHL of the ileocecal tissue samples stained with hematoxylin and eosin 
(original magnifications: a= x 200; b = x 400). c & d illustrate the corre-
sponding serial section to which the EBV/EBEA probe was applied, depict-
ing EBV/EBER staining as blue/purple color (arrow) in the diffuse B-cell 
lymphoma cells (original magnifications: c ::: x 200; d = x 40~). e ~ f are 
serial sections to which a negative control probe was apphed With no 
staining present (original magnifications: e::: x 200; f:::: x 400). 
In the second EBV/EBER-positive case reported in our study, 
positive EBV signals were seen in the lymphoma cells of the 
ileocecal specimen. To our knowledge, there has been only one 
case report study that looked at the presence of EBVIEBER in 
NHL of the ileocecum, which was in a western patient.l81 This 
report described the case of an 8-year-old boy who developed an 
ileocecal B-ee]) lymphoma after liver transplantation. EBV lEBER 
was demonstrated to be present in lymphoma cells and hyperplasic 
~ 2006 Adis Data Information BV. AB rights reseNed. 
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follicular germinal center cells in various ileocecal tissue sam-
ples.l81 
Our study is the first to investigate the presence ofEBVIEBER 
in NHL of the rectum. 
It is not known what role latent EBV infection played in the 
development of the two cases of NHL of the lower GI tract 
reported to be EBV positive in this study. However, it has been 
suggested£201 that the reason for detecting EBVIEBER in a small 
percentage of gastric carcinomas could be the presence of EBV 
reservoir lymphocytes that may randomly reach the GI tract muco-
sa, as do other inflammatory cells. Epithelial cells may therefore 
become exposed to EBV derived from these reservoir lympho-
cytes. 
Conclusions 
This study demonstrates a rare association between EBV and 
NHL of the lower GI tract in our study population. In addition, our 
study may indicate that anti-herpesvirus drug therapy may prove 
to be effective in the future for similar cases. In order to confirm 
and implement this therapeutic approach using anti-herpesvirus 
drugs, more studies on GI tract lymphoma tissue samples will be 
necessary. 
Acknowledgements 
The authors would like to thank Dr Haji Ramli Saad. Director of the 
Advanced Medical and Dental Institute, Universiti Sains Malaysia (USM). for 
providing laboratory facilities and for his financial suppon. Also, the authors 
would like to thank Professor Abdul Rashid Abdul Rahman, USM, for his 
continuous suppon. Finally, the authors would like to thank Professor Rahmah 
Noordin at the Institute for Research in Molecular Medicine. USM, for 
allowing us to use her laboratory equipment. 
The authors have no conflicts of interest that are directly relevant to the 
content of this study. 
References 
I. Young LS. Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2()().4: 4 
Suppl. 10: 757-68 
2. Rickinson AB, Kieff E. In: Fields BN. Knipe E. Howley PM. editors. Epstein-Barr 
virus, fields virology. 3rd ed. Vol. 2. Philadelphia (PA): Lippincott-Raven. 
1996: 2397-446 
3. Peh SC. Hos~ ethnicit~ influen~es. non-Hodgkin"s lymphoma subtype frequency 
and Epstem-Barr varus assoc1a11on rate the experience of a muhi-ethnic patient 
population in Malaysia Histopathology 2001: 38 Suppl. 5: 458-65 
4. Muller AM. lhorst G, Menelsmann R. et al. Epidemiology of non-Hodgkin's 
lymphoma CNHL): trends, geographic distribution. and etiology. Ann Hematol 
2005; 84 Suppl. I: 1-12 
5. Fahraeus R. Fu HL. Emberg I, et al. Expression of Epstein-Barr virus-encoded 
proteins in nasopharyngeal carcinoma. lnt J Cancer 1988: 42 Suppl. 3: 329-38 
6. Lee SS, Jang JJ, ~o KJ. ~~ al. Epstein-Barr virus-associated primary gastrointesti-
nal lymphoma m non-tmmunocompromised patients in Korea Histopathology 
1997; 30 Suppl. 3: 234-42 
7. Wong NA. Herbst H, Herrmann K, et al. Epstein-Barr virus infection in colorectal 
neoplasms associated with inflammatory bowel disease: detection of the virus 
in lymphomas but not in adenocarcinomas. J Pathol 2003: 201 Suppl. 2:312-8 
Mol Diog Ther 2006: 10 (4) 
256 
8. Sadahira y, Kumori K, Mikami Y, et al. Post-lransplant malignant lymphoma with 
monoclonal immunoglobulin gene rearrangement and polyclonal Epstein-Barr 
virus episomes. J Clin Patho12001; 54 Suppl. 11: 887-9 
9. Borisch B. Hennig I. Horber F, et al. Enteropathy-associated T -cell lymphoma in a 
renal transplant patient with evidence of Epstein-Barr virus involvement 
Virchows Arch A Pathol Anat Histopathol 1992; 421 Suppl. 5: 443-7 
10. Yang WI, Cho MS. Tomita Y, et al. Epstein-Barr virus and gastrointestinal 
lymphomas in Korea. Yonsei Med J 1998; 39 Suppl. 3: 268-76 
II. Kersten MJ, Surachno S. Koopman MG. et al. Epstein-Barr virus in a donor kidney 
as a cause of non-Hodgkin lymphoma. Ned 1ijdschr Geneeskd 1999; 143 
Suppl. 7: 360-4 
12. Gulley ML. Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol 
Diagn 2001; 3 Suppl. 1: 1-10 . 
13. Leong IT, Fernandes BJ. Mock D. Epstein-Barr virus detectio_n i~ non-H~gk1~'s 
lymphoma of the oral cavity: an immunocytochemical and m sttu hybndtzauon 
study. Oral Surg Oral Med Oral Pathol 2001; 92 Suppl. 2: 184-93 
14. Glickman JN. Howe JG, Steitz JA. Structural analyses of EBER 1 and EBERl 
ribonucleoprotein panicles present in Epstein-Barr virus-infected cells. J Virol 
1988; 62 Suppl. 3: 902-11 
15. GiJJigan K, Rajadurai P. Resnick L, et al. Epstein-Barr virus _small nuclear R_NAs 
are not expressed in permissively infected cells m AIDS-assoctated 
leukoplakia. Proc Natl Acad Sci US A 1990 Nov: 87 (22): 8790-4 
C 2006 Adis Doto Information BV All rights reserved. 
Yunos et al. 
16. Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in 
clinical specimens. Am J Pathol 1994 Aug: 145 (2): 239-52 
17. Harris NL. Jaffe ES, Stein H. et al. A revised European-American classification of 
lymphoid neoplasms: a proposal from the International Lymphoma Study 
Group. Blood 1994 Sep 1; 84 (5): 1361-92 
18. Peh SC. Nadarajah VS, Tai YC, et al. Pattern of Epstein-Barr virus association in 
childhood non-Hodgkin's lymphoma: experience of university of Malaya medi-
cal center. Pathol tnt 2004: 54 Suppl. 3: 151-7 
19. Quintanilla-Martinez L, Lome-Maldonado C, Ott G. et al. Primary non-Hodgkin·s 
lymphoma of the inteStine: high prevalence of Epstein-Barr virus in Mexican 
lymphomas as compared with European cases. Blood 1997 Jan 15; 89 (2): 
644-51 
20. Cho YJ, Chang MS. Park SH, et al. In situ hybridization of Epstein-Barr virus in 
tumor cells and tumor-infiltrating lymphocytes of gastrointestinal trocL Hum 
Pathol2001; 32 Suppl. 3: 297-301 
Correspondence and offprints: Professor Mohamed J.E.M.F. Mabruk, Ad-
vanced Medical and Dental Institute, Universiti Sains Malaysia, Komplex 
Eureka, Penang, 11800 USM, Malaysia. 
E-mail: mmabruk03@yahoo.co.uk 
Mol Diag Ther 2006. 10 (4) 
BERGMANN-LEITNER ES, DUNCAN EH, MULLEN GE, BURGE JR, KHAN F, LONG CA, 
ANGOV E & LYON JA, 2006. Critical evaluation of different methods for measuring the functional 
activity of antibodies against malaria blood stage antigens. American journal of tropical medicine 
and hygiene, 75 (3), 437-442. 
2 
Am. J. Trop. Mt!d. llyg., 75(3), 2006. pp. 437-442 
Copyright C 2006 by The American Society cf Tropical Medicine and Hygiene 
CRITICAL EVALUATION OF DIFFERENT METHODS FOR MEASURING THE 
FUNCTIONAL ACfiVITY OF ANTIBODIES AGAINST MALARIA BLOOD 
STAGE ANTIGENS 
ELKE S. BERGMANN-LEITNE~ * ELIZABETH H. DUNCAN, GREGORY E. MULLEN, JOHN ROBERT BURGE, 
FARHAT KHAN, CAROLE A. LONG, EVELINA ANGOV, AND JEFFREY A. LYON 
Department of Immunology, CD&./, Walter Reed Army Institute of Research, Silver Spring, Maryland; Malaria Vaccine Development 
Branch, N/AIDINJH, Rockville, Maryland 
Abstract. Antibodies are thought to be the primary immune effectors in the defense against erythrocytic stage 
Plasmodium falciparum. Thus, malaria vaccines directed to blood stages of infection are evaluated based on their ability 
to induce antibodies with anti-parasite activity. Such antibodies may have different effector functions (e.g., inhibition of 
invasion or inhibition of parasite growth/development) depending on the target antigen. We evaluated four methods 
with regards to their ability to differentiate between invasion and/or growth inhibitory activities of antibodies specific for 
two distinct blood stage antigens: AMAl and MSP142. We conclude that antibodies induced by these vaccine candidates 
have different modes of action that vary not only by the antigen, but also by the strain of parasite being tested. Analysis 
based on parasitemia and viability was essential for defining the full range of anti-parasite activities in immune sera. 
INTRODUCTION 
Antibodies directed against bloodstage malaria have been 
shown to be efficacious in the prevention of disease as shown 
in passive transfer experiments in humans.1- 3 The mecha-
nisms by which the antibodies neutralize parasites in vitro 
differ greatly depending on the target antigen. Modalities in-
clude merozoite opsonization, targeting them toward phago-
cytic cells of the host,4 prevention of invasion,5 inhibition of 
parasite development within the erythrocyte,6·7 and interfer-
ence with merozoite dispersal by agglutination.8·9 Most meth-
ods for analyzing functional antibodies against bloodstage 
parasites in vitro are based on microscopic evaluation of 
blood smears or detection of DNA in erythrocytes and do not 
assess parasite viability.8 •10-12 In contrast, the measurement 
of enzymatic activity of the parasite-derived lactate dehydro-
genase (pLDH), 13·14 the conversion of dihydroethidine to 
ethidium,15·16 and the quantification of 3H-hypoxanthine in-
corporation into newly synthesized DNA17'18 all assess para-
site viability and thus can measure both invasion and growth 
inhibition. 
The objective of this study was to compare parasite inhibi-
tion results obtained with four methods that measure either in 
vitro invasion inhibition or growth inhibition (viability) using 
a model system comprised of antigen-specific immune sera 
and 3D7 as well as FVO parasite cultures. Antisera were 
raised against the 307 and FVO alleles of AMA1 19 and 
MSP142,20•21 antigens that are candidates for bloodstage ma-
laria vaccines. Invasion inhibition was measured by quantify-
ing parasites in Giemsa-stained blood smears and by flow 
cytometric analysis of parasites whose DNA was stained with 
Syto 16.22 Whereas staining with Giemsa can reveal antibody-
induced, morphologic changes in parasite development, con-
cluding that these changes also affect parasite viability is sub-
jective. Syto16 readily permeates membranes of both viable 
and non-viable cells and is therefore not useful for measuring 
cell viability. Growth inhibition (viability) was measured by 
*Address correspondence to Elke S. Bergmann-Leitner, Depart· 
ment of Immunology, Walter Reed Anny Institute of Research, 503 
Robert Grant Avenue, Silver Spring, MD 20910. E-mail: elkc. 
bcrgmannlcitncr@us.anny.mil · 
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flow cytometric analysis of parasites whose DNA was stained 
by using hydroethidine (HE) and by measuring the enzymatic 
activity of pLDH.13'14 HE staining depends on the intracel-
lular conversion of HE into ethidium by NADPH oxidase and 
has been described in various protozoan systems including 
malaria to be a reliable metabolic indicator of parasite viabil-
ity.tS.16 
Comparing the four techniques in our model system al-
lowed us to determine that these Abs function either by in-
vasion inhibition or by growth inhibition and that the mecha-
nism of inhibition depended on the parasite test strain. In 
cases where Abs acted by invasion inhibition, all four meth-
ods gave similar results. As observed previously, AMA1-
specific Abs were invasion inhibitory ,2324 whereas antibodies 
directed against MSP142 preferentially inhibited invasion or 
inhibited parasite growth and development, depending on the 
parasite test strain. This study clearly shows that, when ana-
lyzing bloodstage malaria parasite-specific antibodies, meth-
ods that can distinguish between invasion inhibition and vi-
ability of the intraerythrocytic parasite must be used to more 
fully define the Ab mechanism of action. 
MATERIALS AND METHODS 
Parasite cultures. Complete medium was prepared with 
RPMI 1640 (Invitrogen, Carlsbad, CA) containing 25 mmol/L 
HEPES, 7.5% wt/vol NaHC03, and 10% human pooled se-
rum (blood type 0+ ). Plasmodium falciparum strains 3D7 
and FVO were maintained and synchronized by the tempera-
ture cycling method.25 
For the evaluation of immune sera, triplicate cultures were 
set up in replicate culture plates in the presence or absence of 
20 vol% immune serum -6 hours before rupture occurred 
(starting parasitemia, 0.3%; 1% hematocrit uninfected ervth-
rocytes) in 96-well plates under static conditions. Repli~ate 
culture plates were set up to preclude repeated sampling at 
different time-points from the same plate, ruling out sampling 
effect on the growth of the parasites. Time-points indicated 
refer to time after schizont rupture in every experiment. Thus, 
each time-point was collected from its own plate and analyzed 
by the va_rious methods in triplicate. All experiments were 
repeated mdependently at least three times. 
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Antisera. New Zealand White rabbits (Spring Valley Labo-
ratories, Woodbine, MD) were immunized subcutaneously 
four times with either recombinant MSP142 of the FVO strain 
(36136136/36 f.'..&, six rabbits)21 or the 3D7 strain (200/50/50/50 
J.Lg, five rabbits)20 emulsified in complete/incomplete Fre-
und's adjuvant (Sigma-Aldrich, St. Louis, MO), and serum 
pools were prepared. Antisera against recombinant AMAl of 
the FVO and the 307 strains were raised in individual rabbits 
after immunizing intramuscularly three times with 50 J.L& 
PpAMAl using Montanide ISA 720 (SEPPI C. Fairfield, NJ) 
as adjuvant. 19 Pooled control sera were prepared from sera of 
four rabbits immunized three times with 50 J.L& of reduced/ 
alkylated MSP142 (3D7) and MSP142 (FVO) in complete/ 
incomplete Freund's adjuvant. 
Microscopic analysis. Cultures were harvested at various 
time-points as indicated, and blood smears were made from 
each well. Blood smears were fixed in methanol and stained in 
a 10% Giemsa solution: (Sigma) for 10 minutes. Slides were 
washed in water and allowed to air dry before analysis. Evalu-
ation was performed at xlOO magnification (oil immersion) 
using a Nikon (Nikon, Tokyo, Japan) E400 Eclipse. Three 
slides per group were evaluated by counting 2,000 red blood 
cells (RBCs) or 100 parasitized RBCs/slide. Growth inhibi-
tion was calculated using the following formula: percent 
growth inhibition = (1 - (parasitemia of culture/parasitemia 
of control culture]) x 100. 
Flow cytometry. Cells were recovered at different time-
points, and a 50-J.LL aliquot was transferred into polystyrene 
tubes (Becton Dickinson, Mountain View, CA) for subse-
quent staining with hydroethidine (Polysciences, Warrington, 
PA) or Syto16 (Molecular Probes, Eugene, OR). Stock solu-
tions of HE were prepared at 10 mg/ml dissolved in dimeth-
ylsulfoxide (DMSO) (Sigma) and stored at -30°C. Sanjples 
were stained by adding 500 J.LL of freshly diluted HE (diiuted 
1:200 in 37°C phosphate buffered saline [PBS]; BioWhittaker, 
Walkersville, MD) to the parasite suspensions and incubated 
for 20 minutes at 37°C. Syto16, purchased as a 1 mmol/L solu-
tion, was diluted to 200 runol/L with PBS; a 500-J.LL aliquot 
was added to the parasite suspensions and incubated for 30 min-
utes at 37°C. To stop the staining for both methods, samples 
were transferred to ice (which allowed stabilization of the 
staining for up to 2 hours) and were diluted with 1 mL PBS 
before analysis. The data were acquired by a FACSCalibur 
flow cytometer (Becton Dickinson) using CellQuest soft-
ware for acquisition and analysis. Growth inhibition was cal-
culated using the following formula: percent growth inhibi-
tion = (1 - (parasitemia of culture/parasitemia of control 
culture]) x 100. 
LDH assay. Cultures for growth inhibition assays were set 
up at the schizont stage in 96-well plates and cultured for one 
cycle (i.e., 40 hours for 307, 48 hours for FVO). Cells were 
harvested, washed, and frozen at -30°C until analysis. pLDH 
was detected and measured as described elsewhere.26 Growth 
inhibition was calculated using the following formula: % growth 
inhibition = {1 - {[ODsamplc - ODRscJI[ODcontrol serum -
ODRBc))} X 100. 
Statistical methods. Results from detection of growth/ 
invasion inhibition obtained using Syto16 and HE in three 
independent experiments were compared with the Student t 
test (two-tailed). For comparing the results of all four assays, 
the Box-Cox power transformation was used to stabilize vari-
ance in the data. Differences in growth inhibitory activity 
among these factors were evaluated by using an analysis of 
variance technique for a 3 x 4 factorial experiment of a ran-
domized block design and adjusted for multiple comparisons 
with Tukey's simultaneous test (family error rate = 5% ). 
Results from the two parasite test strains were evaluated 
separately. 
RESULTS 
Microscopic analysis of invasion/growth inhibitory effects 
of bloodstage-specific antisera. Parasite cultures were estab-
lished at the early schizont stage in the presence of immune or 
control sera. The AMA !-specific sera were only tested 
against the homologous strain, whereas anti-MSP142 was 
tested against both homologous and heterologous strains. Fig-
ure 1 summarizes the microscopic evaluation of blood smears 
stained with Giemsa. The graphs show the mean percentage 
of reduction in parasitemia and the 95% CI of 307 (Figure 
1A) and FVO (Figure 1B) cultures at various time-points 
during the bloodstage cycle. For this analysis, every parasit-
ized cell was counted as one invasion event including cells 
infected with multiple parasites. We counted all parasites as-
sociated with RBCs, i.e., rings as well as residual schizonts. 
We did not exclude these residual schizonts from the parasit-
emia analysis because of the possibility that they may rupture 
at a later time-point and produce a delayed new burst of 
young rings. In three independent experiments conducted 
with 3D7 parasite cultures, treatment with MSP142 (307)-
specific, MSP142 (FVO)-specific, and AMA1 (307)-specific 
antisera caused an overall reduction of parasitemia by 13%, 
25%, and 46%, respectively. Similarly, with FVO parasite 
cultures, treatment with MSP1 42 (307)-specific, MSP1 42 
(FVO)-specific, and AMA1 (FYO)-specific antisera caused 
an overall reduction of parasitemia by 10%, 52%, and 42%, 
respectively. To determine if any of the antibodies merely 
delay development rather than inhibit growth, we extended 
the analysis by 6 hours after the second round of invasion was 
completed. Typically for the in vitro culture conditions, the 
307 and FVO strains, have cycle lengths of 40 and 48 hours, 
respectively. Thus, for the extended analysis, 307 and FVO 
cultures were collected 48 and 58 hours, respectively, after the 
initial invasion event. No delays were observed (data not 
shown). 
Comparison of DNA-binding dyes Sytol6 and HE for their 
ability to measure the effect of bloodstage-specific antisera on 
parasite viability. We next explored flow cytometric analysis 
as a means for automated measurement of the anti-parasitic 
effects of immune sera, because analysis by Giemsa-stained 
blood typically is time consuming and high throughput 
screening is difficult. Sytol6 staining is useful for detecting the 
presence of DNA but is not able to distinguish between live 
and dead cells,22 whereas HE has been described in various 
protozoan systems including malaria as a vital stain for viable 
• IS 16 · h · parasttes, · owmg to t e reqmrement that parasite-derived 
enzymes convert hydroethidine to ethidium. 
Results from Sytol6 and HE staining (Figure 2), in a single 
cycle assay, for homologous strain pRBC cultured with 
AMAl-specific Ab (FYO strain P. falciparum cultured with 
anti-AMAl [FVO) or 307 strain-cultured with AMA-1 
[3D7]) were essentially identical, indicating that all inhibition 
by AMA1-specific Abs is by invasion inhibition. 
In the case of MSPI42-specific Abs, the situation was more 
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complex. By 6 hours after invasion, detection with Syto16 or 
HE showed that anti-MSP142 (307)-specific antiserum sup-
pressed homologous 307 strain parasite growth only margin-
ally compared with control serwn (11% inhibition). By the 
end of the experiment, there was no change in the ~ount of 
inhibition observed by staining with Sytol6, but the amount 
of inhibition measured by staining with HE increased signifi-
cantly to 22.6% (two-sample t test, P = 0.02, two-tailed). This 
was also the case when 307 parasites were treated with het-
erologous anti-MSP1 42 (FVO) antiserum, although the over-
all levels of inhibition were higher (Sytol6, 25% inhibition; 
HE, 44% inhibition, two-sample t test, P = 0.038, two-tailed). 
These results indicate that the primary effect of these antisera 
on 307 strain parasites was inhibition of development rather 
than inhibition of invasion. 
In contrast, when FVO strain parasites were treated with 
either homologous anti-MSP142 (FVO) or heterologous anti-
MSP142 (307) antisera, Syto16 and HE staining detected 
similar levels of inhibition throughout the experiment. By the 
end of the experiment, the inhibition by anti-MSP142 (FVO) 
antisera, as detected by Syto16 and HE, was 51 o/o and 53%, 
respectively (P = 0.87) and was substantially greater than the 
inhibition with the anti-MSP142 (307) antisera (5% and 9o/o, 
respectively, P = 0.31). These results indicate that the pri-
mary effect of antisera against the two alleles of MSP142 when 
tested against FVO strain P. falciparum is invasion inhibition. 
Thus, we were able to discern the different effects of the 
antisera on the various test strains by comparing results from 
DNA staining using Syto16 and the vital stain HE. 
Measurement of parasite metabolic activity. Last, we 
sought to confirm the parasite growth inhibition detected with 
HE staining by quantifying pLOH levels. Figure 3 is repre-
sentative of three experiments and shows that the parasites 
must reach early trophozoite stage to produce enough pLDH 
to meet the threshold of detection. It also shows that the 
measurement of pLOH activity is optimal at the end of 
schizogony because the 00 values are maximal at this time. 
pLDH levels were not different in 307 strain cultures that 
were either not treated or treated with pooled control sera, 
whereas pLOH levels in FVO strain cultures that were 
treated with pooled control sera were slightly higher than in 
untreated cultures. Both of the anti-MSP142 (307) and 
(FVO)-specific sera caused growth inhibition when tested 
against the homologous parasite strain (21% and 60%, re-
spectively) as well as the heterologous strain (20% and 41%, 
respectively). Considering the kinetics of the pLOH measure-
ment and the trends observed for the various treatments, we 
conclude that measuring pLOH is a sensitive method for de-
tecting viable parasites that were able to invade and continue 
to develop into trophozoites and schizonts in the presence of 
immune serum. 
Comparison of the methods for measuring the growth in-
hibitory activity of immune sera. Figure 4 summarizes the 
mean levels of growth inhibition induced by three specific 
anti-sera (anti-MSP142 (307], anti-MSP142 [FVO], and anti-
AMAl), each evaluated using four different methods (Gi-
emsa, Sytol6, HE, and pLOH) against the two parasite 
strains. In each test strain, the antisera produced similar pat-
terns of inhibition among the four methods. Testing for the 
interaction between factors, antisera and method, was not 
significa?t. In addition, analysis of variance revealed signifi-
cant mam effects among methods and among antisera. The 
differences in growth inhibition among the four methods were 
st~onger forth~ 3?7 test strain [F(3,18) = 13.9, p < 0.001] but 
sttll reached s1gmficance in the FVO strain [F(3,18) = 3.2, 
P = 0.048]. To further evaluate differences among the four 
methods, Tukey's post hoc test procedure was used. For the 
307 test strain, there was no difference in detection of inhi-
bit.ion between the pair Giemsa and Syto16 or between the 
pa1r HE and pLDH, but detection of inhibition by either 
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Giemsa or Sytol6 was significantly less sensitive than detec-
tion by HE or pLDH. For the FVO test strain, pLDH con-
sistently showed the strongest detection of inhibition across 
all three antisera; however, the Tukey procedure failed to 
reject any pairwise differences between methods. 
DISCUSSION 
The evaluation of vaccines directed against the bloodstages 
of P. falciparum often consists of measuring vaccine induced 
antibody titers (e.g., by ELISA) in preclinical models and 
correlating these titers with some biologically relevant func-
tional activity. It is widely considered that measuring the 
growth inhibitory capacity of an immune serum or antibody 
preparation will be one of the prime components for such an 
immune correlate. When selecting a technique for the evalu-
ation of parasite inhibitory activities within immune sera, sev-
eral aspects should be considered: 1) what does the selected 
technique actually measure, i.e., parasitemia or metabolic ac-
tivity, 2) how sensitive and reproducible is the assay, and 3) 
how feasible is the sample preparation for large scale screen-
ing of sera. This study focuses on the first two points and 
compares the results obtained from methods that are based 
on either measurement of parasitemia and/or viability/ 
metabolic activity of parasites. Figure 4 summarizes the in-
hibitory effect of the anti-MSP142 and anti-AMA 1 antisera, as 
measured by microscopic analysis of blood smears, and flow 
cytometric analysis using Syto16, both of which measure par-
asitemia, as well as by flow cytometric analysis with HE and 
measuring pLDH, both of which measure parasite viability. 
Comparison of the results from the four methods by use of a 
general linear model shows that 307 strain parasites treated 
with anti-MSP142 antisera were more susceptible to killing by 
mechanisms that affect parasite viability than by inhibition of 
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invasion, whereas FVO strain parasites treated with the same 
antisera seemed to be most susceptible to invasion inhibition. 
When treated with homologous antisera specific for AMAl, 
both strains were neutralized by invasion inhibition. 
The idea that parasite viability can be affected by anti-
MSPl Ab after invasion is plausible owing to the fact that 
MSPl-specific Abs coat merozoites and can be found on the 
surface of ring stage parasites after invasion.27 Our observa-
tion that MSP1 4 rspecific antisera can affect intracellular 
parasite viability is consistent with the results of another re-
cent study, in which MSPl-specific antisera affected the pro-
gression of intracellular parasite development. 7 In that study, 
Giemsa-stained parasites were evaluated for their morpholo-
gies, and flow cytometry was used to differentiate and quan-
tify parasite populations based on DNA content by staining 
with propidium iodide. We prefer to measure viability by 
either of the methods presented above over measurement of 
DNA content with propidium iodide because gate settings are 
subjective and vary between experiments, and it is not pos-
sible to distinguish between retarded trophozoite stage and 
newly developing ring stage parasites. 
Our data showed that invasion inhibitory activities of Ab 
can be measured by any of the methods used in this study, 
whereas growth inhibitory activities are best measured by us-
ing methods that determine viability. We also show that some 
Ab work by more than one modality, which can vary with the 
test strain. We propose that the evaluation of bloodstage-
specific antisera for preclinical or clinical evaluations include 
techniques that are based on vital stains such as HE and/or 
measurement of parasite metabolic activity such as the pLDH 
assay. These methods measure both invasion and growth in-
hibition and therefore reveal a greater portion of the spec-
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trum of anti-parasite activities associated with the Ab being 
tested. We further propose that other unidentified parasite 
phenotypes might also be affected by Ab and that learning to 
measure these may also be useful for developing immune 
correlates. 
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Concordance between endoscopic and 
histological gastroesophageal reflux disease 
The gold standard for diagnosis of erosive 
Gastroesophageal reflux disease (GERD) is upper 
gastrointestinal endoscopy while there is presently 
no gold standard for the diagnosis for non-erosive 
GERD (NERD). 1 Tho~:~gh 24-hour esophageal pH 
monitoring can confirm ·the diagnosis of GERD, it is 
not widely available. Patients without obvious 
esophageal erosions arc treated with a two-week 
course of proton pump inhibitor and their symptom 
response evaluated (PPI test). Histology does not 
appear to play a significant role in the diagnosis of 
GERD. 2•3 
y- February 
Eighty-one patients (median age 49 years, range 
13-80; 42 male) who had reflux symptoms and were 
referred for upper GI endoscopy were recruited into 
the study. History of treatment with acid-suppres-
sive drugs was noted and consent taken for esoph-
ageal biopsy. At endoscopy esophageal mucosa was 
assessed by trained endoscopists, and mucosal breaks 
classified using the LA classification. 4 Biopsies taken 
at 3 em above the gastroesophageal junction were 
evaluated by a single pathologist, blind to the clinical 
findings. A histological diagnosis of GERD was made 
when there was coexistence of basal cell hyperpla-
sia greater than 15°/o of mucosal thickness and pap-
illary height greater than 50% of mucosal thick-
ness. 5 Alcian blue/periodic acid Schiff (AB-PAS) stain 
was used to delineate the basal layer of the squa-
mous epithelium (which is glycogen-depleted) and 
to demonstrate the presence of intestinal metaplasia 
in Barrett's esophagus. 
The predominant symptom was retrosternal pain 
(66 subjects), followed by indigestion (54). Classi-
cal reflux symptoms of heartburn and regurgitation 
were elicited in 43.2% (35) and 38.3% (31) of sub-
jects, respectively. Regurgitation was the only symptom 
that correlated significantly with endoscopy-positive 
GERD (Fisher's exact test, p=0.006). 
Thirty six of the 81 subjects (44.4%) had ero-
sive GERD with a majority having mild grades, i.e., 
LA grade A - 25 subjects, grade B - 7 subjects, 
grade C - 1 subject and grade D - 3 subjects. The 
esophageal mucosa was endoscopically normal in 39 
(48.1 %) subjects. Other findings included Barrett's 
esophagus ( 1 patient), white patches on esophageal 
mucosa (2), benign stricture ( 1 ), irregular Z line ( 1) 
and esophageal web (I). Hiatus hernia was present 
in 4 cases. 
Histological GERD was diagnosed in 33.3% (27/ 
8I) of subjects. Less than half ( I5/36) the number 
of patients with erosive esophagitis showed histo-
logical evidence of GERD. In LA grade A, 9 of 25 
subjects had histological GERD; grade B - 3 of 7 
subjects; grade C - I of I subject and grade C - 2 
of 3 subjects. In contrast, I2/45 subjects (26.7°/o) 
with non-erosive esophageal mucosa had evidence 
of histological GERD. Sixteen of 44 patients with 
classical reflux symptoms had evidence of histologi-
cal GERD. The present study reports a 4.9°/o (4/81) 
prevalence of Barrett's esophagus by histology, which 
is slightly higher compared to other studies. 6 One of 
the 2 patients who had white patches on endoscopy 
had Candida infection. Two of the four cases with 
hiatus hernia had histological evidence of GERD. 
Lener~ 
There was no significant difference in the presence 
of histological GERD between patients who had 
previous treatment with acid-suppressive agents and 
those who did not (Fisher's exact test, p=0.06). 
One of the major findings in this study is the 
poor concordance between erosive GERD and histo-
logical evidence of GERD, throughout all the grades 
of the LA classification (k value of 0.04 to 0.07). 
When all LA grades were grouped together as 'en-
doscopic GERD' and normal endoscopy was classi-
fied as 'no GERD', the agreement between endos-
copy and histology remained poor (k value 0.16). 
The concordance between endoscopy and histology 
was poor (k value 0.025) even taking into consider-
ation only patients with classical symptoms of G ERD. 
In conclusion, most patients in the present study 
suffered from NERD or mild erosive esophagitis. 
The macroscopic appearance of esophageal erosions 
did not correlate with classical histological features 
of reflux esophagitis. Conversely, a normal-looking 
esophagus was not proof of histologically normal 
mucosa. 
Gurjeet Kaur, Sharifah Emilia Tuan Shariff. 
Syed Hassan Syed Abd Aziz, Amry A Rahim. 
Sarimah Abdullah 
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BRIEF REPORTS 
Cross-Cultural Differences in Somatic Presentation in 
Patients With Generalized Anxiety Disorder 
Elizabeth A. Hoge, MD,* Sharad M Tamrakar, MD, t Kelly M Christian, BS, * 
Namrata Mahara, MD, t Mahendra K. Nepal, MD, t Mark H. Pollack. MD.* 
and Naomi M Simon, MD, MSc* 
Abstract: Little is known about cultural differences in the expres-
sion of distress in anxiety disorders. Previous cross-cultural studies 
of depression have found a greater somatic focus in Asian popula-
tions. We examined anxiety symptoms in patients with generalized 
anxiety disorder (GAD) in urban mental health settings in Nepal 
(N = 30) and in the United States (N = 23). Participants completed 
the Beck Anxiety Inventory (BAI). The overall BAI score and 
somatic and psychological subscales were compared. While there 
was no difference in total BAI scores, the Nepali group scored 
higher on the somatic subscale (i.e. ''dizziness" and "indigestion," 
t[dj] = -2.63[50], p < 0.05), while the American group scored 
higher on the psychological subscale (i.e. "scared" and "nervous," 
t[dj] = 3.27[50], p < 0.01). Nepali patients with GAD had higher 
levels of somatic symptoms and lower levels of psychological 
symptoms than American patients with GAD. Possible explanations 
include differences in cultural traditions of describing distress and 
the mind-body dichotomy. 
Key Words: Cross-cultural comparison, anxiety disorders, 
transcultural studies. 
(J Nerv Ment Dis 2006;194: 962-966) 
M ood and anxiety disorders generally include symptoms comprised of somatic experiences (e.g., fatigue or pal-
pitations) as well as psychological experiences (e.g., feeling 
sad or afraid). "Somatization" generally refers to the presen-
tation of medically unexplained physical symptoms without 
reference to possible psychological origins (Kellner, 1990). 
In this article to avoid confusion about the term "somatiza-
tion," which ~ay suggest somatoform disorders, we will use 
the term "somatic presentation," which instead refers t? the 
patient's reported physical symptoms, separate from the 1ssue 
of the patients' perceived cause of these symptoms. 
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Many studies have reported a higher rate of somatic 
symptom presentation in Asian versus Western patients with 
depression. For example, Kleinman ( 1977) examined patients 
with depressive disorders in Taiwan and in America, and 
found that 88% of the Taiwanese patients first presented with 
somatic complaints, compared with 16% of the American 
patients. Similarly, Kleinman and Kleinman ( 1985) inter-
viewed 100 Chinese patients with depressive disorders, and 
although all of the patients experienced dysphoria, somatic 
complaints were the predominant type of symptom presenta-
tion: 90% reported headaches and 73% reported dizziness as 
their chief complaint. Further, Lin et al. (1985) found that of 
92 Vietnamese patients seeking medical care at an interna-
tional community health center in Washington state, 95% of 
those who later met criteria for a diagnosis of depression 
presented with only physical symptoms such as. h~adache, 
musculoskeletal pain, or shortness of breath. A stmllar em-
phasis on somatic symptoms has been found in studies carried 
out in India, the Philippines, Taiwan, and Hong Kong (for 
review see Cheng, 1989). Other cross-cultural studies have 
not found this difference (Hollifield et al., 2003; Simon et al., 
1999). While this research suggests that some types of symp-
toms are preferentially reported, the patient's causal attribu-
tion (physical or emotional) is not known. 
Previous research on somatic symptoms has focused on 
depression, and there is a relative lack of comparable data 
examining anxiety disorders. However, anxiety disorders 
such as panic disorder and generalized anxiety disorder 
(GAD) include somatic symptoms such as restlessness, mus-
cle tension, sleep disturbance, palpitations, shortness of 
breath and dizziness prominently in their diagnostic criteria, 
so it remains unclear whether the differences seen in depres-
sion also apply to these anxiety disorders. 
In addition, a criticism of previous research is that the 
data was collected in different health settings: Asian patients 
presented to primary care providers, and American patients 
often to mental health providers (Kirmayer, 2001), potentially 
biasing the findings. For example, the presentation in a 
medical or mental health setting may reflect the patient's 
causal attribution of the symptoms as due to a medical or 
psychological problem, respectively. In this study, we at-
tempt to control for this potential confound by comparing 
subjects who present to mental health providers with a "chief 
complaint" of anxiety. The groups were both studied in a 
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psychiatry department in an urban general hospital, one in 
Boston, Massachusetts, the other in Kathmandu, Nepal. We 
hypothesized that Nepali individuals with GAD would have a 
greater somatic focus when asked about symptoms than 
American participants with GAD. 
METHODS 
Subjects 
Subjects were male and female outpatients age 18 to 75 
with GAD by DSM-IV criteria as assessed by the Structured 
Clinical Interview for DSM-IV (SCID-IV; First et al., 1997). 
Thirty subjects (33% female) were recruited from the general 
psychiatry clinic at the Tribhuvan University Teaching Hos-
pital in Kathmandu, Nepal, and 23 (39% female) from the 
Center for Anxiety And Traumatic Stress Disorders Research 
Program at the Massachusetts General Hospital in Boston, 
Massachusetts. 
Interview and Diagnosis 
Thirty consecutive patients presenting with a chief 
complaint of anxiety were assessed at the Tribhuvan Univer-
sity Teaching Hospital in Kathmandu, Nepal, with the trans-
lated version of the anxiety disorders section of the SCID-IV 
(First et al., 1997). Translation and back-translation of this 
instrument had been performed by Nepali study staff 
(S.M. T. and N. R.). Individuals with evidence of psychotic 
disorder were excluded. Patients who met criteria for GAD 
completed the Beck Anxiety Inventory (BAI), a 21-item 
questionnaire previously validated in Nepali (Beck et al., 
1988; Kohrt et al., 200 1 ). These instruments were used a.s part 
of standard clinical monitoring in this clinic, and were ap-
proved by the director of the Tribhuvan University Teaching 
Hospital. 
American subjects were recruited from those with a 
primary diagnosis of GAD who had participated in a treat-
ment study in 2003 and 2004. Subjects completed the BAI at 
baseline assessment, prior to treatment initiation. The Insti-
tutional Review Board at the Massachusetts General Hospital 
approved all studies, and all participants received and signed 
informed consent prior to study entry. At the initial interview, 
subjects were diagnosed with GAD using the SCID-IV; 
patients with a history of bipolar disorder or schizophrenia 
were excluded. 
Instruments 
The BAI is a 21-item Likert self-report questionnaire 
measuring common symptoms of anxiety, such as "nervous" 
and '1mable to relax." Each symptom is rated on a 4-point 
scale ranging from 0 (not at all) to 3 (severely, I could barely 
stand it), with possible total scores ranging from 0 to 6~. 
K.abacoff et al. ( 1997) performed a factor analysts of 
the BAI item pool, and found a two-factor structure, with one 
factor describing somatic aspects of anxiety and the other 
describing subjective aspects of anxiety comprised of psy-
chological symptoms. We used these factors to examine 
separately the somatic items as a "somatic subscale" and the 
psychological items as a "psychological subscale" (Table 1 ). 
TABLE 1. Beck Anxiety Inventory Subscale Items 
Somade Subscale Items 
Numbness or tingling 
Feeling hot 
Wobbliness in legs 
Dizzy or lightheaded 
Hean pounding or racing 
Unsteady 
Feeling of choking 
Hands trembling 
Shaky 
Difficulty breathing 
Indigestion or discomfon in abdomen 
Faint 
Face flushed 
Sweating (not due to heat) 
Psychological subscale items 
Unable to relax 
Fear of worst happening 
Terrified 
Nervous 
Fear of losing control 
Fear of dying 
Scared 
Although DSM-IV diagnostic information was not 
available for the Nepali group, we felt it important to examine 
whether any differences seen might be explained by differ-
ences in depression comorbidity. Thus, we used a Beck 
Depression Inventory (BDI) score, completed concurrently 
with the BAI, to detect the possible presence of a major 
depressive episode. Prior research has found a score of 15 or 
higher on the BDI to have high sensitivity and specificity as 
an indicator of a major depressive episode (areas under the 
receiver operating characteristic curves of 0.81 and 0.93; 
Viinamaki et al., 2004). For the American group, the comor-
bidity of current major depressive disorder was determined 
by the SCID-IV. 
Data Analysis 
As there was no evidence that the total BAI scores were 
not normal on tests of skewness and kurtosis, two-sided t tests 
were used to analyze group differences in overall mean 
scores, subscale scores, and individual item scores of the 
BAl. Linear regression analyses were used to adjust for age 
~d gend~r. We ~ed a p value of 0:05 for statistical signif-
Icance, Without adjustment for multiple testing. 
RESULTS 
There was no significant difference in gender between 
the two groups, but the American sample was significantly 
older (mean = 45 :!: 15 years) versus (mean = 31 :!: 7 years; 
t[dj] = 4.44~58], p < 0.001 ). We compared the overall BAI 
score, som~ttc and .psychological subsca1es, as well as single 
symptom Item ratmgs for the Nepali and American GAD 
groups. The total BAI score was not significantly different 
between the Nepali (mean total score = 15 :!: 4.0) and the 
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American (mean total score = 14.7 ± 7.4) groups (t[dj] = 
-0.19[ 49], p = 0.8). Nepali subjects had higher scores on the 
somatic subscale (Nepal group = 10.4 ± 3.1, American 
group = 7.5 ± 4.6; t[dj] = -2.63[50], p < 0.05), while 
American subjects had higher scores on the psychological 
subscale (Nepal group= 4.6 ± 1.9, American group= 7.3 ± 
4.0, t[dj] = 3.27[50], p < 0.01). Single items that were 
significantly higher in the Nepal group were "numbness or 
tingling" (p < 0.00 I), "wobbliness in legs" (p < 0.00 I), 
"dizzy or lightheaded" (p < 0.001), "feeling of choking" 
(p < 0.001), "indigestion or discomfort in abdomen" (p < 
0.001), "feeling hot" (p < 0.05), "hands trembling" (p < 
0.05), and "faint" (p < 0.05). Items significantly higher in the 
American group were "unable to relax" (p < 0.001 ), "ner-
vous" (p < 0.0 I), and " fear of dying" (p < 0.05; see Figures 
I to 3). The number of subjects in the analyses fluctuates 
because of single missing items for two subjects (American), 
who were not included in the total score analyses or relevant 
subscale analyses. 
Although there was no significant difference in rates of 
current depression comorbidity in the two samples (FET p = 
NS), 33.3% (10/30) of the Nepali sample and 13.0% (3/23) of 
the US sample were found to have a current major depressive 
episode; this Jack of statistical significance may be due to the 
relatively small sample size. Thus, to control for the potential 
contribution of age, gender, and depression comorbidity, we 
performed a regression analysis of each BAI subscale score 
with these covariates. For the psychological subscale, scores 
remained lower for the Nepali group compared with the US 
group (group {3 = - 2.44, 1 = - 2.31, p = 0.03 ), and somatic 
subscale scores were higher for the Nepali compared with the 
US group (group {3 = 2.88, 1 = 2.18, p = 0.03 ). 
DISCUSSION 
We found that Nepali patients with GAD had higher 
rates of somatic complaints than the American patients with 
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GAD. This study of GAD is consistent with prior studies of 
depression showing that individuals from Asian cultures, 
relative to those from Western cultures, tend to emphasize 
somatic symptoms in depression. Va:ious explanations have 
been given for the tendency to focus on somatic symptoms. 
Some researchers have hypothesized that stigmatization of 
mental illness in some cultures leads patients to minimize 
emotional distress and emphasize somatic symptoms. How-
ever, our data suggest that even patients seeking care in a 
mental health sening report more somatic symptoms, sug-
gesting the need to explore explanations beyond stigma. For 
example, some researchers have emphasized the importance 
of the cultural conceptualization of health: traditional medi-
cine in many parts of Asia does not distinguish between mind 
and body, making distinctions in symptom type irrelevant and 
increasing the likelihood that individuals will manifest 
psychological distress with somatic symptomatology (Hsu, 
1999). Another theory suggests that Asian cultures do not 
have the same semantic framework for conceptualizing or 
expressing affect (Tseng, 1973) and are less inclined toward 
intense introspection of personal affective states than are 
those from Western cultures. In this way, some emotions may 
be difficult to articulate. Cultural factors may also influence 
acceptable panems of expression, leading to increased dis-
comfort in discussing emotional difficulties. A focus on 
somatic presentation of psychological distress is observed in 
a variety of cultures, and some researchers have pointed out 
that since it is more widely found, it may represent the norm, 
and that the Western "psychologization" is the panem that 
merits explanation (Hsu and Folstein, 1997). 
Regardless, it is important to note that symptom pre-
sentation style does not necessarily indicate the patient's 
explanatory model of their symptoms. For example, in his 
review on the subject of somatization, Kirmayer (200 1) 
suggested that somatic presentation may serve as a "ticket 
Beck Anxiety Inventory 
Figure 1. Comparison of total scores 
and subscale scores for the BAI in 
Nepali and American GAD subjects. TotaJ score Somatic SubscaJe Psychological SubscaJe 
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behavior'' with the somatic symptom serving as "an appro-
priate and nonstigmatized reason to seek help from a biomed-
ical practitioner." In this way, the patient can access help 
even if they see the cause of their symptoms as psychological 
or a result of stress. In exploring the patient's perceived cause 
of somatic symptoms, some researchers have reported that 
Asian patients are more likely to persist in attributing somatic 
complaints to physical causes, even when psychosocial 
causes are suggested (Hsu and Folstein, 1997). Others have 
found this pattern to exist equally in Western and non-
Western cultures (Kirmayer, 200 I). However, our data do not 
allow dissection of these possibilities. 
Limitations of this study include a relatively small 
sample size and lack of adjustment for multiple testing. 
• • • p<O.(l01 
Figure 3. Comparison of individual 
items of the BAI somatic subscale in 
Nepali and American GAD subjects. 
Further research in this area should use larger sample sizes 
from more than one site per country, and should measure the 
effect of comorbid depression. In addition, it is possible 
differences between a clinical versus research patient popu-
lation may be relevant. Some researchers have noted that 
pat~ents participating i~ ~ research trial may not represent 
patients m a general chmcal practice, because research ex-
clusion criteria may affect comorbidity patterns and illness 
severity (Zimmerman et a!., 2002). However, in the present 
study, BAI total scores, reflecting severity of GAD, were the 
s~.e for the r.esearc~ a~d clinical populations. In addition, 
stmtlar .excl.usiOn cntena were employed in both groups: 
psychotic dtsorders were excluded but depression was al-
lowed as long as GAD was the primary disorder (i.e., causing 
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the most distress). Finally, while our finding remained after 
controlling for current comorbid depression, our detennina-
tion of current depression differed for the two groups. 
General medical practitioners should be aware of this 
somatic focus when evaluating patients from different cul-
tures, since the focus on somatic symptoms may obscure 
psychological or emotional distress. Even when the patient's 
chief complaints are of a purely somatic nature, careful 
assessment may uncover an extant mental disorder that may 
respond to appropriate treatment and reduce the overall level 
of distress. Further research is needed to understand cultur-
ally based explanatory models for a somatic focus in mood 
and anxiety disorders, and their impact on compliance with 
and response to treatment interventions. 
REFERENCES 
Beck AT, Epstein N, Brown G, Steer RA ( 1988) Related articles, properties. 
J Consult Clin Psvchol. 56:893-897. 
Cheng TA (1989) ·Symptomatology of minor psychiatric morbidity: A 
crosscultural comparison. Psycho/ Med. 19:697-708. 
First MB, Spitzer RL, Gibbon M, Williams JBW ( 1997) Structured Clinical 
Interview for DSM-IV Axis I Disorders. Washington (DC): American 
Psychiatric Press. 
Hollifield M, Finley R, Skipper B (2003) Panic disorder phenomenology in 
urban self-identified Caucasian-non-Hispanics and Caucasian-Hispanics. 
Depress Anxiety. 18:7-17. 
Hsu LK., Folstein MF ( 1997) Soma to form disorders in Caucasian and 
Chinese Americans. J Nerv Ment Dis. 185:382-387. 
Hsu Sl ( 1999) Somatisation among Asian refugees and immigrants as a 
culturally-shaped illness behaviour. Ann Acad Med Singapore. 28:841-
845. 
Kabacoff Rl, Segal DL, Hersen M, Van Hassett VB (1997) Psychometric 
properties and diagnostic utility of the Beck Anxiety Inventory and the 
State-Trait Anxiety Inventory with older adult psychiatric outpatients. 
J Anxiety Disord. 11:33-47. 
Kellner R (1990) Somatization: Theories and research. J Nerv Ment Dis. 
178:150-160. 
Kirmayer U (1984) Cultural affect and somatization. Transcultural Psychi-
atr Res Rev. 21:159-188. 
Kirmayer U (2001) Cultural variations in the clinical presentation of 
depression and anxiety: Implications for diagnosis and treatmenL J Clin 
Psychiatry. 62:22-28. 
Kleinman A, Kleinman J (1985) Somatization: The interconnections in 
Chinese society among culture. depressive experiences and the meaning of 
pain. In A Kleinman, B Good (Eds), Culture and Depression (pp 429-
490). Berkeley: University of California Press. 
Kleinman A ( 1977) Depression. somatization and the .. new cross-cultural 
psychiatry." Soc Sci Med. 11:3-10. 
Kohrt BA, Kunz RD. Koirala NR, Sharma VD, Nepal MK (2001) Validation 
of the Nepali version of Beck Depression Inventory. Nepalese J Psychi-
atry. 2:123-130. 
Lin EH. lhle U, Tazuma L (1985) Depression among Vietnamese refugees 
in a primary care clinic. Am J Med. 78:41-44. 
Simon GE, VonKorff M. Piccinelli M, Fullerton C, Ormel J (1999) An 
international study of the relation between somatic symptoms and depres-
sion. N Eng/ J Med. 341:1329-1335. 
Tseng WS (1973) The development of psychiatric concepts in traditional 
Chinese medicine. Arch Gen Psychiatry. 29:569-575. 
Viinamaki H, Tanskanen A. Honkalampi K. Koivumaa-Honkanen H, 
Haatainen K. Kaustio 0, Hintikka J (2004) Is the Beck Depression 
Inventory suitable for screening major depression in different phases of the 
disease? Nord J Psychiatry. 58:49-53. 
Zimmerman M. Mattia Jl, Posternak MA (2002) Are subjects in pharmaco-
logical treatment trials of depression representative of patients in routine 
clinical practice? Am J Psychiatry. 159:469-473. 
966 © 2006 Lippincon Williams & Wilkins 
CopyriQht ©Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. 
KAMIL SM, MOHAMAD NH, NARAZAH MY, KHAN FA, 2006. Dengue haemorrhagic fever with 
unusual prolonged thrombocytopaenia. Singapore Medical Journal, 47 (4), 332-334. 
5 
Advanced Medical 
aad Deatallnstilute 
V aivers!ty Sains 
Malaysia 
19 Loroa.g Thmaa 
Bertam ladab 419 
'nunan Ber1am lodah 
IJlOO Kepala Batas 
Pulau Plaang 
Malaysia 
KamiiSM, 
MBBS.FCPS 
Consultant Physician 
andOinical 
Oncologist 
Nanwm MY, MBBS, 
MMcd,PhD 
Consultant 
Khan FA, MBBS, MD 
Consultant 
Hospital Kepala Batas 
IJlOO Kepala Batas 
Pulau Pinaag 
Malaysia 
Moluunad N H, MBBS 
Medical Officer 
Correspondence to: 
Dr Muhammad 
Kamil Sheikh 
Tel: (60)4579200611990 
fa.'<: (60) 579 1570 
Email: kamilpk2001@ 
yahoo.oom 
Case Report Singapore Med J 2006; 47(4) : 332 
Dengue haemorrhagic fever with 
unusual prolonged thrombocytopaenia 
Kamil SM, Mohamad N H, Narazah M Y, Khan F A 
ABSTRACT 
We describe a case of dengue haemorrhaglc 
fever with prolonged thrombocytopaenla. 
A ll-year-old Malay man with no prior 
Illness presented with a history of fever 
and generalised macular rash of four days 
duration. Initial work-up suggested the 
diagnosis of dengue haemorrhaglc fever 
based on thrombocytopaenla and positive 
dengue serology. Patient recovered from 
acute Illness by day ten, and was discharged 
from the hospital with Improving platelet 
count. He was then noted to have declining 
platelet count on follow-up and required 
another hospital admission on day 19 of his 
Illness because of declining platelet count. 
The patient remained hospitalised till day 
44 of his Illness and managed with ·repeated 
platelet transfusion and supportive care till 
he recovered spontaneously. 
Keywords: dengue haemorrhaglc fever, 
macular rash, mosquito, platelet 
transfusion, prolonged thrombocytopaenla, 
thrombocytopaenla 
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INTRODUCTION 
Dengue fever is an acute viral illness. It has a 
spectrum ranging from mild illness to serious 
shock-like state with significant mortality. Dengue 
fever is usually a self-limited mild illness if detected 
early and managed properly. It is transmitted to 
humans by the mosquito Aedes aegypri. Annually. 
there are an estimated 50 to I 00 million cases of 
dengue fever and 250.000 to 500.000 cases of 
dengue haemorrhagic fever (DHF) in the world. 
and over half of the world's population live in 
areas at risk of dengue fever 1.21• The case fatality 
rate in patients with dengue shock syndrome can 
be as high as 44%. The epidemic of dengue fever 
originated in Southeast Asia (Manila) in 1953 
but now the disease has spread to India. Pakistan, 
Sri Lanka and China(l). Dengue fever needs to be 
recognised early and managed properly to decrease 
its mortality. 
CASE REPORT 
A 22-year-old Malay man with no previous past 
medical history, presented with fever and generalised 
macular rash of four days duration. He was residing 
in an army camp and had no history of recent 
travel abroad. He was admitted to hospital with 
a provisional diagnosis of dengue fever. based 
on his low platelet count at presentation. The 
diagnosis of dengue fever was confirmed later by 
positive dengue serology. The patient's platelet 
count was 7,000/}lL(normal range: 150.000-400.000/ 
,14L) at presentation but no active bleeding was noted. 
He was discharged from hospital on day 12 of 
his illness. He required 12 units of platelets to 
maintain his platelet count in the range of 30,000 
to 40.000/}lL. At the time of discharge from 
hospital. his platelet count was 61,000/}lL and he 
was asymptomatic. He was advised regular 
follow-up at a local clinic with regular checks on 
platelet count and the platelet count improved to 
130.000/j4L. 
On day 19 of his illness. his platelet count 
again dropped to 89.000/}lL with a high 
haematocrit. He was again admitted to hospital 
and worked-up for concurrent infection but 
work-up for sepsis was negative. His platelet 
count dropped again and remained low till day 
40 of his illness. and the lowest platelet count 
of 7,000/}lL was noted on day 38. During this 
hospital admission, 35 units of platelets were 
transfused. At this point of time. possibilities of 
underlying platelet disorder or development of 
anti-platelet antibodies were considered but 
the patients' platelet count started improving 
spontaneously by day 39 and reached 163,000/}lL 
on day 44 of his illness. The pattern of prolonged 
thrombocytopaenia with initial recovery was 
unusual in our case. 
DISCUSSION 
Dengue is the most important human viral disease 
transmitted by arthropod vectors. Dengue is a 
homonym for the African Ki denga pepo. which 
first appeared in English literature during an 1827-
28 Caribbean outbreak. Benjamin Rush described 
the first case of dengue in 1789. DHF and dengue 
shock syndrome are now leading causes of 
hospital admissions and deaths among children 
in Asia<341• 
Dengue fever is caused by four dengue viruses 
labelled as types I. 2, 3 and 4. Clinical features of 
dengue virus infection range from mild illness to 
shock leading to death. Dengue fever is an acute 
febrile illness lasting five to six days. Headache. 
retroocular pain. muscle and joint pain. vomiting 
and rash are common manifestations<5•61• The virus 
disappears from the blood after an average of 
five days'7.s1• DHF is characterised by a bleeding 
tendency. secondary to thrombocytopaenia and 
evidence of plasma leakage as determined by 
a rising haematocrit. 
Dengue shock syndrome is defined as dengue 
fever with signs of circulatory failure. The prognosis 
depends on prevention or early recognition and 
treatment. Case fatality rate is as high as 12% to 
14% once shock has set in. Other severe 
manifestations described with dengue syndrome 
include hepatic damage, cardiomyopathy and 
encephalopathy<9•101• In a typical case of dengue 
fever. thrombocytopaenia is seen on days five to 
six. and the mean duration of thrombocytopaenia 
is few days< 111• In our case. thrombocytopaenia 
lasted more than a month after initial recovery. 
This pattern of thrombocytopaenia is unusual 
for dengue. 
Laboratory diagnosis requires serum for 
virological or serological studies. The virus can be 
isolated during the febrile period, which is usually 
around five days. The virus may be isolated utilising 
cell culture and detected rapidly by using PCR 
but this is not available freely and only is 
experimentalo2•. Serological diagnosis requires 
either a presence of IgM antibody or a rise in lgG 
antibody in paired acute and convalescent phase 
serum. IgM antibody may be detected in 90% of 
patients by day six. and will remain positive for 
60 days. 
Currently. the most common IgM assay is a 
capture ELISA (enzyme linked immunosorbent 
assay)<llt. IgG can be measured by haemagglutination 
inhibition test or ELISA. Confirmed diagnosis of 
dengue requires isolation of the virus but a probable 
diagnosis can be made on positive serology. Paired 
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acute and convalescent samples are more suggestive 
of current infection rather than single lgM titre 
which may reflect a recent infection as long as 
30 days ago. 
Management of dengue fever requires rest. oral 
fluids to compensate for losses via diarrhoea or 
vomiting. antipyretics and analgesics. Intravenous 
fluid may be required for few days since the period 
of vasculopathy causing plasma leakage may be 
short. lasting only a few days. Plasma leakage is 
evidenced by a rising haematocrit. Patients who 
present with shock may require central venous 
pressure monitoring. An arterial line may be 
required in unstable patients for the assessment of 
blood gases, electrolytes and coagulation profile 
to help identify patients needing ventilatory 
support. Insertions of vascular lines should be 
done under blood products support in view of the 
thrombocytopaenia and possible coagulopathies. 
Patients should remain in hospital till at least 
day three of recovery from shock. A decision for 
discharge from hospital may be made once the 
patient is stable and platelet counts are greater 
than 50,000/}lL. In our case. the patient suffered 
prolonged thrombocytopaenia following DHF. 
which is unusual for this infection. The possibility 
of the patient acqumng bacterial infection 
during recovery phase leading to sepsis was 
considered. but work-up for sepsis was negative. 
The possibility of underlying platelet disorder was 
also considered. however, the patient recovered 
spontaneously. We postulate that this could be 
an unusual or mutated strain of the dengue virus. 
A further consideration was that the patient 
acquired another infection of dengue virus with 
a different strain during the recovery phase. 
However. the patient was not febrile at the time 
of second presentation to the hospital and the 
isolation of the virus is only possible during the 
short febrile period, which corresponds to the 
period of viraemia. 
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